 |
Bridging Science and Culture to Improve Drug Abuse Research in Minority Communities
This Conference was held at the Wyndham Franklin Plaza hotel in Philadelphia, P.A., September 24-26, 2001.
Biographies (continued)
| |
Steven S. Martin, M.A.
Center for Drug and Alcohol Studies
University of Delaware
77 East Main Street
Newark, DE 19716-2582
(302) 831-6107
(302) 831-3307 Fax
martin@udel.edu
Mr. Martin is a Senior Scientist with the Center for Drug and Alcohol Studies at the University of Delaware. His two main areas of work are the effectiveness of drug treatment for criminal justice offenders and youth substance abuse. He is co-principal investigator (James Inciardi, PI) on the National Institute on Drug Abuse (NIDA) grants for long-term evaluation of the Therapeutic Community Continuum for Offenders in Delaware, and he is principal investigator on a NIDA grant examining HIV prevention interventions among probationers. He is the Evaluator for Delaware's CSAP SIG, conducts Delaware's school surveys of substance abuse, and is co-principal investigator of a NIDA grant (Lana Harrison, PI) to assess the validity of self-report of drug use.
Clyde B. McCoy, Ph.D.
Comprehensive Drug Research Center
University of Miami School of Medicine
Suite 300
1801 NW Ninth Avenue
Miami, FL 33136
(305) 243-7261
(305) 243-3353 Fax
cmccoy@med.miami.edu
Dr. McCoy is a Professor and Chair of the Department of Epidemiology and Public Health and Director of the Comprehensive Drug Research Center at the University of Miami School of Medicine. His research efforts in drug abuse and HIV/AIDS have been federally funded continuously for more than 25 consecutive years.
Lynn McDonald, Ph.D., M.S.W.
Wisconsin Center for Education Research
University of Wisconsin-Madison
1025 West Johnson Street
Madison, WI 53706
(608) 263-9476
(608) 263-6448 Fax
mrmcdona@facstaff.wisc.edu
Dr. McDonald is Director of the Families and Schools Together (FAST) Project and Senior Scientist at the Wisconsin Center for Education Research, University of Wisconsin-Madison. She started a nonprofit, FAST International, to disseminate results from the FAST Project, a preventive intervention involving family therapy programming for low-income populations with adolescent addicts, including multifamily groups. Dr. McDonald was recently appointed to the President's Advisory Council on Youth Drug Use.
Karen Y. Mechanic, M.D.
School of Medicine
Philadelphia Veterans Administration Medical Center
University of Pennsylvania
University and Woodland Avenues
Philadelphia, PA 19104
(215) 823-6387
(215) 823-4248 Fax
mechanic_k@mail.trc.upenn.edu
Dr. Mechanic received her bachelor's degree from Yale College and her M.D. degree from the State University of New York Health Science Center at Brooklyn. She trained in psychiatry at Yale University School of Medicine, where she was also a postdoctoral Fellow and Chief Resident at Yale's Clinical Neuroscience Research Unit.
Dr. Mechanic's research interests include the application of research-proven treatments for substance abuse to community treatment settings.
Richard A. Millstein
National Institute on Drug Abuse
National Institutes of Health
Neuroscience Center, Room 5274
MSC 9581
6001 Executive Boulevard
Bethesda, MD 20892-9581
(301) 443-6481
(301) 443-9127 Fax
millstein@nih.gov
Mr. Millstein is Deputy Director of the National Institute on Drug Abuse (NIDA). He has been instrumental in planning, developing, and implementing NIDA's programs in basic, clinical, epidemiological, and applied scientific research aimed at reducing the burden of drug abuse. Mr. Millstein has served in a variety of roles throughout his career in government service, including a dual role as both Principal Advisor to the Director of the White House Office of National Drug Control Policy and the U.S. Department of Health and Human Services' Liaison on drug demand-reduction activities. He is a recognized expert in the legal, ethical, and policy areas of mental health and addictive disorders. Mr. Millstein has authored and edited a number of key articles on a variety of public health issues. He has twice received the Presidential Executive Rank Award, the highest performance award bestowed on career civil servants.
Eric T. Moolchan, M.D.
Intramural Research Program
Clinical Pharmacology and Therapeutics Research
National Institute on Drug Abuse
National Institutes of Health
P.O. Box 5180
5500 Nathan Shock Drive
Baltimore, MD 21224
(410) 550-1846
(410) 550-2971 Fax
emoolcha@intra.nida.nih.gov
Dr. Moolchan is a physician scientist who directs the Teen Tobacco Addiction Treatment Research Clinic at the National Institute on Drug Abuse Intramural Research Program in Baltimore. He develops and oversees research protocols, with a chief focus on nicotine and tobacco and a secondary focus on other drugs of abuse (cocaine, opioids, and marijuana).
Jonathan Morgenstern, Ph.D.
Mount Sinai School of Medicine
Box 1230
1425 Madison Avenue
New York, NY 10029
(212) 659-8722
(212) 849-2455 Fax
jon.morgenstern@mssm.edu
Dr. Morgenstern is Director of Treatment Research at the National Center on Addiction and Substance Abuse at Columbia University. He is also Associate Professor of Psychiatry and Health Policy and Director of the Alcohol Treatment Program at the Mount Sinai School of Medicine. Dr. Morgenstern's areas of research interest include comorbidity, cognitive behavioral treatment for substance use disorders, and the transfer of knowledge from research to practice. Dr. Morgenstern has a special interest in developing substance abuse treatment services for disadvantaged populations. For the last 5 years he has served as a senior consultant to the New Jersey Department of Human Services and has assisted in the development and evaluation of special services for substance-abusing women on welfare.
Andrew Morral, Ph.D.
RAND
P.O. Box 2138
1700 Main Street
Santa Monica, CA 90407-2138
(310) 393-0411, ext. 7791
(310) 393-4818 Fax
morral@rand.org
Dr. Morral is Associate Director of RAND's Criminal Justice Program and a behavioral scientist in its Drug Policy Research Center. His research interests concern adolescent substance abuse and substance abuse treatments in criminal justice settings. He has worked closely with criminal justice agencies and community treatment providers to develop program evaluation strategies and treatment planning instruments.
Rumi Kato Price, Ph.D., M.P.E.
Department of Psychiatry
Washington University School of Medicine
Suite 2
40 North Kingshighway
St. Louis, MO 63108
(314) 286-2282
(314) 286-2285 Fax
price@rkp.wustl.edu
Dr. Price is an epidemiologist and Research Associate Professor of Epidemiology at Washington University School of Medicine in St. Louis. She holds an Independent Scientist Award from the National Institute on Drug Abuse (NIDA) and is a member of the NIDA Asian American and Pacific Islander Workgroup. She is the principal investigator of several NIH research grants.
Tanya Quille, Ph.D.
Center for Treatment Research on Adolescent Drug Abuse
University of Miami School of Medicine
P.O. Box 019132
Miami, FL 33101
(305) 243-3630
(205) 343-3651 Fax
tquille@med.miami.edu
Dr. Quille is the Clinical Director of the Center for Treatment Research on Adolescent Drug Abuse (CTRADA) and a faculty member in the Department of Epidemiology and Public Health at the University of Miami School of Medicine. As a psychologist, Dr. Quille has worked in the field of adolescent substance abuse for the past 9 years, and, before receiving her doctorate, she worked in the fields of substance abuse and child welfare. Dr. Quille has developed culturally sensitive interventions in her role at CTRADA and has presented nationally on the development of culturally sensitive therapies. Dr. Quille was awarded the Rosalyn Carter Caregiver Award for her work with African American female substance abusers.
Mary Jane Rotheram-Borus, Ph.D.
Neuropsychiatric Institute
University of California, Los Angeles
Suite 350
10920 Wilshire Boulevard
Los Angeles, CA 90024-6521
(310) 794-8280
(310) 794-8297 Fax
rotheram@ucla.edu
Dr. Rotheram-Borus' research interests include HIV/AIDS prevention with adolescents, suicide among adolescents, homeless youths, assessment and modification of children's social skills, ethnic identity, group processes, and cross-ethnic interactions. Dr. Rotheram-Borus has received grants from the National Institute of Mental Health to study HIV prevention with adolescents and persons with sexually transmitted diseases; to study interventions for children whose parents have AIDS and for HIV-seropositive adolescents; and to examine national patterns of use, costs, outcomes, and need for children's and adolescents' mental health service programs.
John Ruffin, Ph.D.
National Center on Minority Health and Health Disparities
National Institutes of Health
Suite 800
6707 Democracy Boulevard
Bethesda, MD 20892-5465
(301) 402-1366
(301) 496-4035 Fax
john_ruffin@nih.gov
Dr. Ruffin was appointed the first Director of the National Center on Minority Health and Health Disparities at the National Institutes of Health (NIH) on January 9, 2001. In this role, he leads the NIH effort to address health disparities in racial and ethnic populations and in other populations experiencing health disparities. The former Director of the NIH Office of Research on Minority Health, Dr. Ruffin developed the largest program in the country promoting biomedical research and research training. A native of New Orleans, Louisiana, Dr. Ruffin received his baccalaureate degree from Dillard University and a master's degree from Atlanta University. He earned a doctorate at Kansas State University in systematic and developmental biology and then pursued postdoctoral studies at Harvard University.
Dr. Ruffin has devoted 25 years of his professional life to improving the health status of minority populations in the United States and to developing and supporting education programs for minority researchers and health care practitioners. Before joining the NIH, he was Dean of the College of Arts and Science at North Carolina Central University. As the Director, Office of Research on Minority Health, NIH, Dr. Ruffin convened an advisory Minority Fact-Finding Team (FFT) to help NIH identify specific minority health concerns and current gaps in minority training. Co-chaired by Dr. Norman Francis, President of Xavier University of Louisiana, and Dr. David Satcher, U.S. Surgeon General and Assistant Secretary for Health, the 53-member FFT included such distinguished members as Dr. Donna Shalala, former Secretary of the U.S. Department of Health and Human Services (DHHS), and the late Dr. Theodore Cooper, a former DHHS Assistant Secretary for Health. The FFT organized three large national meetings involving nearly 1,000 members of minority communities. Their recommendations served as guidelines for the Minority Health Initiative, a set of programs aimed at improving minority health throughout the lifespan and increasing the numbers of underrepresented minorities in the biomedical and behavioral sciences. The Minority Health Initiative received strong support from the Congress and was initially funded at $45 million. Support has steadily increased each year to a current funding level of $130 million for the new National Center on Minority Health and Health Disparities.
Dr. Ruffin's lifelong commitment to academic excellence and promotion of numerous partnerships with government, private industry, and academic institutions to support minority health research and research training have earned him much recognition. He has received the Samuel L. Kountz Award (1997) for his significant contribution to the cause of increasing access and participation in organ and tissue transplantation in minorities, the NIH Director's Award, the National Hispanic Leadership Award, the Beta Beta Beta Biological Honor Society Award, the National Medical Association Award of Appreciation, a Special Recognition Award by the Secretary of Health and Human Services, and, most recently, the Presidential Merit Award.
|
|
[More Biographies][Conference Agenda][Conference Index]
|
|
